Skip to main content

Table 4 The effect of immunosuppressants in the tracheal allograft model

From: The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis

  

Dose

Treatment time

Harvest time

Luminal

Epithelial

  

Animal

Compound

(mg/kg per day)

(days)

(days)

occlusion (%)

loss (%)

n

Reference

Rat

Control

-

0–14

14

31

100

n.r.

[19]

   

0–28

28

96

100

  
 

CsA

5 p.o.

0–14

14

10

80

  
   

7–27

28

64

n.r.

  
 

MPA

40 p.o.

0–14

14

18

100

  
 

LFM

20 p.o.

0–14

14

6

12

  
   

0–28

28

32

85

  
 

RPM

6 i.p.

0–14

14

7

65

  
   

0–28

28

4

100

  
   

7–27

28

8

n.r.

  
 

DSG

2.5 i.p.

0–28

28

20

100

  
   

7–27

28

93

n.r.

  

Rat

Control

-

0–14

14

31

100

5

[20]

   

0–28

28

98

100

5

 
 

CsA

10 p.o.

0–14

14

10

80

5

 
   

0–28

28

32

100

5

 
 

MPA

40 p.o.

0–14

14

18

100

5

 
   

0–28

28

63

100

5

 
 

LFM

20 p.o.

0–14

14

7.9

100

5

 
   

0–28

28

20

100

5

 
 

RPM

6 i.p.

0–14

14

7.5

65

5

 
   

0–28

28

4

100

5

 
 

DSG

2.5 i.p.

0–14

14

5.8

11.7

5

 
   

0–28

28

32

85

5

 

Rat

Control

-

0–13

14

31

 

5

[18]

 

CsA

5 p.o.

0–13

14

0

 

5

 
 

MPA

40 p.o.

0–13

14

0

 

5

 
 

LFM

20 p.o.

0–13

14

0

 

5

 
 

RPM

6 i.p.

0–13

14

0

 

5

 

Mouse

Control

-

0–30

30

89

100

10

[38]

 

CsA

5 i.p.

0–30

30

n.e.

n.e.

7

 
  

10 i.p.

0–30

30

n.e.

n.e.

7

 
  

15 i.p.

0–30

30

n.e.

n.e.

7

 
  

25 i.p.

0–30

30

–19

n.e.

7

 

Mouse

Control

-

 

28

40–90

100

5

[39]

 

RPM

9 i.p.

1–28

28

0 to <–5

0

5

 
  

12 i.p.

14–28

28

0 to <–5

0

5

 

Rat

Control

-

0–30

30

100

100

6

[26]

 

CsA

1 s.c.

0–30

30

100

25

4

 
  

2 s.c.

0–30

30

0

0

4

 
  

5 s.c.

0–30

30

0

0

6

 
 

DSG

1 i.p.

0–30

30

100

100

6

 
 

MPM

2 i.p.

0–30

30

50

50

4

 
  

20 i.p.

0–30

30

100

100

6

 
  

40 i.p.*

0–30

30

100

100

4

 

Rat

Control

-

0–28

28

100

 

n.r.

[32]

 

CsA

5

0–28

28

0

   
 

RPM

6

0–28

28

0

   
 

DSG

2.5

0–28

28

100

   
 

LFM

20

0–28

28

5

   
 

MPA

40

0–28

28

30

   

Rat

Control

-

0–27

28

100

100

All 5–10

[34]

   

0–50

28

100

100

  
 

CsA

10 p.o.

0–27

28

4

0

  
   

7–27

28

14–100

56

  
   

0–49

50

22

0

  
 

MPM

40 p.o.

0–27

28

47

Partial

  
   

7–27

28

93

100

  
 

LFM

20 p.o.

0–27

28

11

Partial

  
   

7–27

28

62

100

  
   

0–49

50

21

19

  
 

RPM

6 i.p.

0–27

28

6

36

  
   

7–27

28

16

100

  
   

14–27

28

72

100

  
   

0–49

50

16

29

  
 

DSG

2.5 i.p.

0–27

28

42

80

  
   

7–27

28

98

100

  

Rat

Control

-

0–3

28

~100

 

6

[36]

 

FK506

0.5 i.m.

0–3

28

~100

 

8

 
  

1 i.m.

0–3

28

~100

 

8

 
  

1.5 i.m.

0–3

28

~30

 

8

 
  1. *Toxic at this dose; CsA, cyclosporin A; DSG, deoxyspergualin; i.m., intramuscularly; i.p., intraperitoneally; MPA, mycophenolic acid; MPM, mycophenolate mofetil; n.e., no effect; n.r., not reported; p.o., orally; RPM, rapamycin; s.c., subcutaneously.